Search
  • Site Search
  • News
  • Product

    • Zhejiang Medical Technology Development Co., Ltd.

    Winhealth Pharma and Kyuan Trade develop new channel cooperation
    Hong Kong Winhealth Pharma Group and Kyuan Xinhai (Beijing) Medical Products Trade Co., Ltd. developed a long-term and comprehensive strategic cooperative partnership on the SPH system distribution of Compound Heparin Sodium and Allantoin Gel (manufactured by Merz Pharma GmbH & Co.KGaA) and Tauroursodeoxycholic Acid Capsules (manufactured by DOPPEL FARMACEUTICI S.R.L) in Hangzhou on October 29, 2019.General Manager Mr. Chu Chenxi and Vice-general Manager Mr. Zhang Dejun from Kyuan Xinhai (Beijing) Medical Products Trade Co., Ltd., President Mr. Wang Wei and Business Operations Director Mr....
    Winhealth Pharma and Kyuan Trade develop new channel cooperation
    Winhealth and JD.COM Pharmacy reached strategic cooperation agreement on Winhealth products
    Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as 'Winhealth Pharma Group') announced the formal establishment of a long-term strategic partnership on total products with JD.com self-operated pharmacy (hereinafter referred to as 'JD.COM Pharmacy').On September 30, 2019, the strategic cooperation signing ceremony between Winhealth Group and JD.COM Pharmacy was held as scheduled at the Beijing headquarters of JD.com. The main leaders attending the signing ceremony were: Hao Jinghui, Chief Commercial Officer; Chen Huiming, Commercial Operation Director; Tan Tian...
    Winhealth and JD.COM Pharmacy reached strategic cooperation agreement on Winhealth products
    2019 Mucosolvan conference for partners nationwide successfully held in Hangzhou
    On September 18, 2019, the 2019 Mucosolvan conference for partners nationwide kicked off at the Hangzhou headquarters. Featuring the theme of 'Win-win cooperation', the conference aimed to encourage partners to jointly develop with Winhealth, and make concerted efforts to promote Mucosolvan®. The representatives of 18 partners nationwide gathered together to witness this occasion.In addition, we were honored to invite Mr. Zeng Chenghui, vice president of Boehringer Ingelheim (China) Investment Co., Ltd and his management team as the guests of this conference. Mr. Wang Wei, board c...
    2019 Mucosolvan conference for partners nationwide successfully held in Hangzhou
    Winhealth won "BD Influence Award"!
    On September 11-12, 2019, the 14th Summit Forum for Medicine and Medical Technology Development in China, which was hosted by China Healthcare Business Development (CHBD), was successfully held in Yantai, Shandong Province.This summit forum was jointly hosted by Winhealth Group and LUYE Pharmaceutical, and more than 200 well-known domestic and foreign pharmaceutical enterprises, industry associations and investment institutions, such as Roche, Novartis, GSK, Xi'an-Janssen, WuXi PharmaTech, Hengrui Medicine, HEC, PwC, McKinsey & Company, and Sequoia Capital, were invited. A total of 7 c...
    Winhealth won "BD Influence Award"!
    Celebration on sales of 3 million boxes of Coniel and elite meeting
    From September 6 to 9, 2019, the 'Honor and Brilliance  Celebration on Sales of 3 Million Boxes of Coniel and Sales Elite Meeting' was held in Kyoto and Osaka, Japan.Mr. Mikayama, director of Kyowa Hakko Kirin Co., Ltd. (hereinafter referred to as 'Kyowa Hakko Kirin'), Mr. Kazunobu Sankawa, board chairman of Kyowa Hakko Kirin (China), Mr. Wang Wei, board chairman/president of Hongkong Winhealth Pharma Group Co., Ltd , leaders, colleagues and sales elites of Hongkong Winhealth Pharma Group Co., Ltd , attended the celebration.On September 6, the celebration was held in Kyoto...
    Celebration on sales of 3 million boxes of Coniel and elite meeting
    Strategic Cooperation Agreement on Flumarin Achieved between Winhealth and Shionogi
    On September 5 2019, Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as “Winhealth Group”) announced that it has entered into a strategic cooperation agreement with Shionogi & Co Ltd (hereinafter referred to as “Shionogi”) for the product Flumarin. Shionogi will grant Winhealth Group the Exclusive License of Flumarin in mainland China, fully authorizing Winhealth of its commercial operation in mainland China from registration, access, marketing, channel management to product life cycle management.Flumenine (cefosporin fluoride), produced by Shionogi & Co Ltd, is a bro...
    Strategic Cooperation Agreement on Flumarin Achieved between Winhealth and Shionogi
    First nationwide channel partner conference of Winhealth Group successfully held in Hangzhou
    On June 14, the first '2019 Winhealth Channel Partner Communication Conference' was held at Hangzhou Marriott Hotel Qianjiang, officially starting the channel cooperation discussion of the CDCO model under Winhealth 2.0. About 200 strategic channel partners and partners in the medical ecological circle from all over the country gathered together to review the past, look into the future, discuss new modes of cooperation and development under the new environment, and reached cooperation intentions in many fields.It was our honor that Zeng Chenghui, vice president of Boehringer Ingelheim ...
    First nationwide channel partner conference of Winhealth Group successfully held in Hangzhou
    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline ）
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.
      网站地图
    浙ICP备12044547号
    Sitemap
    浙公网安备 33010302003458号